98%
921
2 minutes
20
Cardiac metastasis from melanoma is a rare but clinically significant condition often underdiagnosed because of its asymptomatic nature. This retrospective case series examines six patients with metastatic melanoma treated at the University Hospital of Bordeaux who were incidentally found to have cardiac metastases during follow-up. The patients were treated with immune checkpoint inhibitors (ICIs) either alone or combined with surgical excision of cardiac lesions. Outcomes were mixed, with three (50%) patients achieving a complete response, one (16.7%) a partial response, and two (33.3%) experiencing disease progression. Cardiac metastasectomy, when combined with ICI, showed promising results in selected patients, highlighting a potential survival benefit and enhanced tumor control with a multimodal approach. This series emphasizes the importance of considering cardiac metastases in differential diagnosis and underscores the role of imaging in early detection. While ICI therapy shows effectiveness, further studies are needed to refine treatment strategies and improve outcomes for patients with cardiac involvement.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/CMR.0000000000001032 | DOI Listing |
JACC Case Rep
September 2025
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address:
Background: Masses in the right ventricle are uncommon, but if present, they are most often attributed to either primary cardiac tumors or metastatic disease.
Case Summary: A 50-year-old woman presented with progressive lower extremity edema and was diagnosed with a right ventricular mass causing severe tricuspid insufficiency and near-total obstruction of the pulmonary artery. She had a history of hysterectomy for uterine leiomyomatosis.
JACC Case Rep
September 2025
Cardiology Department, University Hospital Álvaro Cunqueiro, Vigo, Spain; Instituto de Investigación Sanitaria Galicia Sur, Vigo, Spain.
Background: Cardiac metastases from choriocarcinoma are exceptionally rare, with only 11 cases reported in the literature to date.
Case Summary: Here we present the case of a 37-year-old woman with progressively worsening exercise intolerance, chest pain, and occasional hemoptysis after childbirth. Initial chest computed tomography revealed a pulmonary mass and a left atrial mass extending from the right inferior pulmonary vein.
Front Oncol
August 2025
Stroke Unit, Emergency Department, Umberto I Hospital, Sapienza University of Rome, Rome, Italy.
The association between ischemic stroke (IS) and malignancy is well established. Cancer-related strokes are predominantly embolic and classified as embolic strokes of undetermined source (ESUS). While malignancy-associated coagulopathy represents the primary pathogenic mechanism, neoplastic embolization of circulating tumor cells is another potential etiology, particularly in cases of cardiac and pulmonary malignancies.
View Article and Find Full Text PDFLancet Oncol
September 2025
Department of Cancer Medicine, Gustave Roussy, Paris-Saclay University, Villejuif, France.
Background: No standard treatment exists for patients with platinum-refractory advanced type B3 thymoma and thymic carcinoma. In the PECATI trial, we sought to assess the antitumour activity and safety of lenvatinib plus pembrolizumab in this population.
Methods: In this single-arm phase 2 trial, we recruited participants from 11 hospitals in France, Italy, and Spain.
Medicine (Baltimore)
August 2025
Key Laboratory of Evidence Science, China University of Political Science and Law, Ministry of Education, Beijing, China.
Rationale: Large cell lung carcinoma (LCLC) is a rare undifferentiated malignant epithelial tumor of the lung. The diagnostic complexity of LCLC stems from its pronounced histological heterogeneity and diverse clinical presentation, particularly when extrapulmonary manifestations constitute the initial disease presentation, complicating early detection.
Patient Concerns: A 58-year-old smoker presented with acute-onset dizziness, lethargy, and communication difficulties lasting 1 day.